Selected research
Industry Research
Enzymes for β-lactam Antibiotics Industry Research Report 2026
Market perspective
The global Enzymes for β-lactam Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Enzymes for β-lactam Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Enzymes for β-lactam Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Enzymes for β-lactam Antibiotics include MCE, Amicogen, Biosynth, Crawford Wisdom International, Creative Enzymes, Fermenta Biotech Ltd., Merck & Co., MuseChem Chemicals and Biolab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Enzymes for β-lactam Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enzymes for β-lactam Antibiotics Market by Company
MCE
Amicogen
Biosynth
Crawford Wisdom International
Creative Enzymes
Fermenta Biotech Ltd.
Merck & Co.
MuseChem Chemicals
Biolab
Hangzhou Chuangke Biotech
Hangzhou Junfeng Bioengineering
Hunan Fulaige Biotech
Shanghai Kekai Biotech
Enzymes for β-lactam Antibiotics Segment by Type
Penicillin Acylase
β-lactamase
Other
Enzymes for β-lactam Antibiotics Segment by Application
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other
Enzymes for β-lactam Antibiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzymes for β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzymes for β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzymes for β-lactam Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enzymes for β-lactam Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enzymes for β-lactam Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enzymes for β-lactam Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Penicillin Acylase
- β-lactamase
- Other
Applications
- Cephalosporins
- Penicillin and Its Derivatives
- Monoamide Ring
- Other
Companies covered
- MCE
- Amicogen
- Biosynth
- Crawford Wisdom International
- Creative Enzymes
- Fermenta Biotech Ltd.
- Merck & Co.
- MuseChem Chemicals
- Biolab
- Hangzhou Chuangke Biotech
- Hangzhou Junfeng Bioengineering
- Hunan Fulaige Biotech
- Shanghai Kekai Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Enzymes for β-lactam Antibiotics Market Size (2021-2032)
- 2.2.2 Global Enzymes for β-lactam Antibiotics Sales (2021-2032)
- 2.2.3 Global Enzymes for β-lactam Antibiotics Market Average Price (2021-2032)
- 2.3 Enzymes for β-lactam Antibiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Penicillin Acylase
- 2.3.3 β-lactamase
- 2.3.4 Other
- 2.4 Enzymes for β-lactam Antibiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cephalosporins
- 2.4.3 Penicillin and Its Derivatives
- 2.4.4 Monoamide Ring
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Enzymes for β-lactam Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Enzymes for β-lactam Antibiotics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Enzymes for β-lactam Antibiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Enzymes for β-lactam Antibiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Enzymes for β-lactam Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Enzymes for β-lactam Antibiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Enzymes for β-lactam Antibiotics, Product Type & Application
- 3.8 Global Manufacturers of Enzymes for β-lactam Antibiotics, Established Date
- 3.9 Global Enzymes for β-lactam Antibiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 MCE
- 4.1.1 MCE Company Information
- 4.1.2 MCE Business Overview
- 4.1.3 MCE Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 MCE Enzymes for β-lactam Antibiotics Product Portfolio
- 4.1.5 MCE Recent Developments
- 4.2 Amicogen
- 4.2.1 Amicogen Company Information
- 4.2.2 Amicogen Business Overview
- 4.2.3 Amicogen Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amicogen Enzymes for β-lactam Antibiotics Product Portfolio
- 4.2.5 Amicogen Recent Developments
- 4.3 Biosynth
- 4.3.1 Biosynth Company Information
- 4.3.2 Biosynth Business Overview
- 4.3.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
- 4.3.5 Biosynth Recent Developments
- 4.4 Crawford Wisdom International
- 4.4.1 Crawford Wisdom International Company Information
- 4.4.2 Crawford Wisdom International Business Overview
- 4.4.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio
- 4.4.5 Crawford Wisdom International Recent Developments
- 4.5 Creative Enzymes
- 4.5.1 Creative Enzymes Company Information
- 4.5.2 Creative Enzymes Business Overview
- 4.5.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
- 4.5.5 Creative Enzymes Recent Developments
- 4.6 Fermenta Biotech Ltd.
- 4.6.1 Fermenta Biotech Ltd. Company Information
- 4.6.2 Fermenta Biotech Ltd. Business Overview
- 4.6.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio
- 4.6.5 Fermenta Biotech Ltd. Recent Developments
- 4.7 Merck & Co.
- 4.7.1 Merck & Co. Company Information
- 4.7.2 Merck & Co. Business Overview
- 4.7.3 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio
- 4.7.5 Merck & Co. Recent Developments
- 4.8 MuseChem Chemicals
- 4.8.1 MuseChem Chemicals Company Information
- 4.8.2 MuseChem Chemicals Business Overview
- 4.8.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio
- 4.8.5 MuseChem Chemicals Recent Developments
- 4.9 Biolab
- 4.9.1 Biolab Company Information
- 4.9.2 Biolab Business Overview
- 4.9.3 Biolab Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Biolab Enzymes for β-lactam Antibiotics Product Portfolio
- 4.9.5 Biolab Recent Developments
- 4.10 Hangzhou Chuangke Biotech
- 4.10.1 Hangzhou Chuangke Biotech Company Information
- 4.10.2 Hangzhou Chuangke Biotech Business Overview
- 4.10.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 4.10.5 Hangzhou Chuangke Biotech Recent Developments
- 4.11 Hangzhou Junfeng Bioengineering
- 4.11.1 Hangzhou Junfeng Bioengineering Company Information
- 4.11.2 Hangzhou Junfeng Bioengineering Business Overview
- 4.11.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio
- 4.11.5 Hangzhou Junfeng Bioengineering Recent Developments
- 4.12 Hunan Fulaige Biotech
- 4.12.1 Hunan Fulaige Biotech Company Information
- 4.12.2 Hunan Fulaige Biotech Business Overview
- 4.12.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 4.12.5 Hunan Fulaige Biotech Recent Developments
- 4.13 Shanghai Kekai Biotech
- 4.13.1 Shanghai Kekai Biotech Company Information
- 4.13.2 Shanghai Kekai Biotech Business Overview
- 4.13.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 4.13.5 Shanghai Kekai Biotech Recent Developments
5 Global Enzymes for β-lactam Antibiotics Market Scenario by Region
- 5.1 Global Enzymes for β-lactam Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021-2032
- 5.2.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021-2026
- 5.2.2 Global Enzymes for β-lactam Antibiotics Sales by Region: 2027-2032
- 5.3 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021-2032
- 5.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021-2026
- 5.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2027-2032
- 5.4 North America Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
- 5.4.1 North America Enzymes for β-lactam Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 5.4.3 North America Enzymes for β-lactam Antibiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
- 5.5.1 Europe Enzymes for β-lactam Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 5.5.3 Europe Enzymes for β-lactam Antibiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Enzymes for β-lactam Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Enzymes for β-lactam Antibiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
- 5.7.1 South America Enzymes for β-lactam Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 5.7.3 South America Enzymes for β-lactam Antibiotics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Enzymes for β-lactam Antibiotics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2032)
- 6.1.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021-2032)
- 6.2.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Enzymes for β-lactam Antibiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2032)
- 7.1.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021-2032)
- 7.2.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Enzymes for β-lactam Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Enzymes for β-lactam Antibiotics Value Chain Analysis
- 8.1.1 Enzymes for β-lactam Antibiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Enzymes for β-lactam Antibiotics Production Mode & Process
- 8.2 Enzymes for β-lactam Antibiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Enzymes for β-lactam Antibiotics Distributors
- 8.2.3 Enzymes for β-lactam Antibiotics Customers
9 Global Enzymes for β-lactam Antibiotics Analyzing Market Dynamics
- 9.1 Enzymes for β-lactam Antibiotics Industry Trends
- 9.2 Enzymes for β-lactam Antibiotics Industry Drivers
- 9.3 Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges
- 9.4 Enzymes for β-lactam Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst